Related Experiment Video
Updated: May 9, 2026
07:04
Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
COMMD1 modulates noxious inflammation in cystic fibrosis
Alix de Becdelièvre1, Jérémy Rocca, Abdel Aissat
1INSERM U955, Créteil 94010, France; Université Paris-Est, Créteil 94010, France; AP-HP, CHU H. Mondor, Pôle de Biologie, Créteil 94010, France.
The International Journal of Biochemistry & Cell Biology
|July 30, 2013
Summary
COMMD1 protein has anti-inflammatory properties beneficial for cystic fibrosis (CF) lung disease. It inhibits NF-κB activity, reducing inflammatory cytokines like IL-8, offering potential new CF therapies.
Area of Science:
- Cell Biology
- Genetics
- Immunology
Background:
- Cystic fibrosis (CF) is an inherited disorder affecting the CFTR gene, leading to lung disease characterized by chronic inflammation.
- Inflammation in CF airways involves dysregulated NF-κB signaling and elevated pro-inflammatory cytokines, such as IL-8.
- COMMD1 protein interacts with CFTR and influences its cell surface expression.
Purpose of the Study:
- To investigate the role of COMMD1 in regulating NF-κB inflammatory pathways in bronchial epithelial cells from CF and non-CF individuals.
- To determine if COMMD1 possesses anti-inflammatory properties relevant to CF pathogenesis.
Main Methods:
- Utilized knockdown and overexpression techniques to manipulate COMMD1 levels in bronchial epithelial cells.
- Assessed NF-κB-dependent transcriptional activity and IL-8 levels (mRNA and protein) in response to COMMD1 modulation.
Main Results:
- COMMD1 knockdown led to increased NF-κB-dependent transcription, indicating COMMD1 normally suppresses this pathway.
- COMMD1 overexpression significantly inhibited NF-κB activity.
- Overexpression of COMMD1 resulted in reduced IL-8 transcript levels and protein secretion.
Conclusions:
- COMMD1 exhibits significant anti-inflammatory properties in bronchial epithelial cells.
- COMMD1's ability to inhibit NF-κB and reduce IL-8 points to its therapeutic potential for managing inflammation in cystic fibrosis lung disease.
More Related Videos
Related Concept Videos
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:28Inflammatory Response
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...